Your browser doesn't support javascript.
loading
Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation.
Tassone, Flora; Protic, Dragana; Allen, Emily Graves; Archibald, Alison D; Baud, Anna; Brown, Ted W; Budimirovic, Dejan B; Cohen, Jonathan; Dufour, Brett; Eiges, Rachel; Elvassore, Nicola; Gabis, Lidia V; Grudzien, Samantha J; Hall, Deborah A; Hessl, David; Hogan, Abigail; Hunter, Jessica Ezzell; Jin, Peng; Jiraanont, Poonnada; Klusek, Jessica; Kooy, R Frank; Kraan, Claudine M; Laterza, Cecilia; Lee, Andrea; Lipworth, Karen; Losh, Molly; Loesch, Danuta; Lozano, Reymundo; Mailick, Marsha R; Manolopoulos, Apostolos; Martinez-Cerdeno, Veronica; McLennan, Yingratana; Miller, Robert M; Montanaro, Federica Alice Maria; Mosconi, Matthew W; Potter, Sarah Nelson; Raspa, Melissa; Rivera, Susan M; Shelly, Katharine; Todd, Peter K; Tutak, Katarzyna; Wang, Jun Yi; Wheeler, Anne; Winarni, Tri Indah; Zafarullah, Marwa; Hagerman, Randi J.
Afiliação
  • Tassone F; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
  • Protic D; MIND Institute, University of California Davis, Davis, CA 95817, USA.
  • Allen EG; Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11129 Belgrade, Serbia.
  • Archibald AD; Fragile X Clinic, Special Hospital for Cerebral Palsy and Developmental Neurology, 11040 Belgrade, Serbia.
  • Baud A; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Brown TW; Victorian Clinical Genetics Services, Royal Children's Hospital, Melbourne, VIC 3052, Australia.
  • Budimirovic DB; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC 3052, Australia.
  • Cohen J; Genomics in Society Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC 3052, Australia.
  • Dufour B; Department of Gene Expression, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University, Uniwersytetu Poznanskiego 6, 61-614 Poznan, Poland.
  • Eiges R; Central Clinical School, University of Sydney, Sydney, NSW 2006, Australia.
  • Elvassore N; Fragile X Association of Australia, Brookvale, NSW 2100, Australia.
  • Gabis LV; NYS Institute for Basic Research in Developmental Disabilities, New York, NY 10314, USA.
  • Grudzien SJ; Department of Psychiatry, Fragile X Clinic, Kennedy Krieger Institute, Baltimore, MD 21205, USA.
  • Hall DA; Department of Psychiatry & Behavioral Sciences-Child Psychiatry, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.
  • Hessl D; Fragile X Alliance Clinic, Melbourne, VIC 3161, Australia.
  • Hogan A; MIND Institute, University of California Davis, Davis, CA 95817, USA.
  • Hunter JE; Department of Pathology and Laboratory Medicine, Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children of Northern California, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
  • Jin P; Stem Cell Research Laboratory, Medical Genetics Institute, Shaare Zedek Medical Center Affiliated with the Hebrew University School of Medicine, Jerusalem 91031, Israel.
  • Jiraanont P; Veneto Institute of Molecular Medicine (VIMM), 35129 Padova, Italy.
  • Klusek J; Department of Industrial Engineering, University of Padova, 35131 Padova, Italy.
  • Kooy RF; Keshet Autism Center Maccabi Wolfson, Holon 5822012, Israel.
  • Kraan CM; Faculty of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.
  • Laterza C; Department of Neurology, University of Michigan, 4148 BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA.
  • Lee A; Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA.
  • Lipworth K; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA.
  • Losh M; Department of Neurological Sciences, Rush University, Chicago, IL 60612, USA.
  • Loesch D; MIND Institute, University of California Davis, Davis, CA 95817, USA.
  • Lozano R; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
  • Mailick MR; Department of Communication Sciences and Disorders, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.
  • Manolopoulos A; RTI International, Research Triangle Park, NC 27709, USA.
  • Martinez-Cerdeno V; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • McLennan Y; Faculty of Medicine, King Mongkut's Institute of Technology Ladkrabang, Bangkok 10520, Thailand.
  • Miller RM; Department of Communication Sciences and Disorders, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.
  • Montanaro FAM; Department of Medical Genetics, University of Antwerp, 2000 Antwerp, Belgium.
  • Mosconi MW; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC 3052, Australia.
  • Potter SN; Diagnosis and Development, Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia.
  • Raspa M; Veneto Institute of Molecular Medicine (VIMM), 35129 Padova, Italy.
  • Rivera SM; Department of Industrial Engineering, University of Padova, 35131 Padova, Italy.
  • Shelly K; Fragile X New Zealand, Nelson 7040, New Zealand.
  • Todd PK; Fragile X Association of Australia, Brookvale, NSW 2100, Australia.
  • Tutak K; Roxelyn and Richard Pepper Department of Communication Sciences and Disorders, Northwestern University, Evanston, IL 60201, USA.
  • Wang JY; School of Psychology and Public Health, La Trobe University, Melbourne, VIC 3086, Australia.
  • Wheeler A; Departments of Genetics and Genomic Sciences and Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Winarni TI; Waisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
  • Zafarullah M; Intramural Research Program, Laboratory of Clinical Investigation, National Institute on Aging, Baltimore, MD 21224, USA.
  • Hagerman RJ; MIND Institute, University of California Davis, Davis, CA 95817, USA.
Cells ; 12(18)2023 09 21.
Article em En | MEDLINE | ID: mdl-37759552
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína do X Frágil da Deficiência Intelectual / Síndrome do Cromossomo X Frágil Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Cells Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína do X Frágil da Deficiência Intelectual / Síndrome do Cromossomo X Frágil Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Cells Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos